Gilead Sciences Canada is the Canadian affiliate of a global biopharmaceutical company that discovers, develops, and commercializes innovative medicines for life-threatening illnesses, including HIV, liver diseases, cancer, and inflammatory and respiratory conditions. The Canadian operation, established in 2006, supports commercial, medical, and regulatory functions, operates a research and process manufacturing facility in Edmonton, and engages in partnerships to address Canadian health challenges and improve access to care.